The present work deals with the design of 7-azaindole derivatives for its Raf-B inhibition. All the designed compounds follows Lipinski's rule of five. In silico ADME predictions of all the designed compounds suggests that none of the compounds have problem with bioavailability. The compounds were designed on the binding affinity towards the Raf-B inhibition. It was observed that few of the designed compounds were found to have significant interaction with the active site of the receptor. The compounds possessing 3-hydroxyl-2-methyl as substitution in chalcone was found to possess maximum docking score than other designed compounds.
Introduction
The Raf family kinases consist of three isoforms: A-Raf, B-Raf and C-Raf. B-Raf represents an interesting target for anticancer drug development as it is mainly involved in the Ras-Raf-MEK-ERK signal transduction pathway participating in cell proliferation and cell survival [1, 2] . B-Raf kinase is found to frequently mutate in melanomas, with the Val600/ Glu600 (V600E) transition representing the most common mutation [3] , accounting for over 90% in all of the B-Raf oncogenic mutants reported to date. Furthermore, this mutation type causes B-Raf to signal independently from upstream regulation [4] . The clinical approval of Vemurafenib and Dabrafenib for the treatment of metastatic melanoma bearing the B-RafV600E mutation has further confirmed that B-RafV600E may be an attractive target for anticancer therapy [5] .
Molecular docking is used routinely to predict the binding strength of ligands in the target [6] . The efficacy of molecular docking may be significantly enhanced through discriminatory analysis for the selection of docking scores [7] .
7-azindole derivatives have been found to be an important scaffold in the anticancer drug like Vemurafenib [8] . Chalcone derivatives have been an important class of compounds which is used as anticancer agents [9] . Hence conjugating the azaindole ring with chalcone could improve the binding affinity of compound which in turn the pharmacological activity increases.
As part of our continued interest in drug design of Raf-B inhibitors as anticancer agents, the present strategy, involves designing for chalcone derivatives of 7-azaindole as Raf-B inhibitors by docking study.
Experimental Methods

Drug-Likeness Evaluation
Drug-likeness rules are used for fast calculation of druglike properties of a molecule. The predicted drug-likeness properties [10] like molecular weight, AlogP, Hydrogen bond donars, Hydrogen bond acceptors and number of rotatable bonds were reported in Table 1 .
ADME Studies
All the designed compounds were subjected to absorption, distribution, metabolism and excretion descriptors using Discovery Studio 3.5. This study provides the insight into the pharmacokinetic property of the designed compounds [11] . The results were depicted in Fig. 1 . 
Docking
Preparation of the Target Protein
The crystal structure of Raf-B (pdb: 4EHG) active site was employed as the template for molecule docking [12] . All crystallographic water molecules were removed. Hydrogen atoms were added using CHARMm force field. The site for docking was selected from the receptor cavity and protein was prepared using protein preparation tool.
Ligand Preparation
Aza indole based ligand library was prepared and minimized using CHARMm force field [13] . The ligands were designed on the basis of binding group of azaindole to fit into the 1CX2 effectively. Methyl, amino, hydroxy, chloro, bromo, iodo, fluro, and nitro groups in phenyl ring were considered as mono or substituent form in chalcone. These compounds were designed on the basis of the binding affinity and the target specificity. A total of 12 compounds were designed for the docking study. All conformers were treated with the ligand minimization of the receptor ligand interaction module. Minimized ligand and protein were used for the docking studies.
Docking Studies
To identify the molecule binding interaction of the designed compound with the target, all the compounds were docked into the active sites of both the targets. Computational studies of novel azaindole derivatives where carried out using Discovery Studio 3.5. CDOCKER interaction energy, hydrogen bonding and the interacting amino acid involved in the binding where used to predict the effect of binding with the target. The results of docking were listed in Table 2 . Docking poses were mentioned in Figs. 2 and 3. 
Results and Discussion
In this research work, we have designed 12 compounds for its possible Raf-B inhibition. All the minimized ligands were carried out for their ADME studies. All the compounds were well in accordance to the ADME parameters. It suggest that the compounds does not have any problem with the ADME. All the designed compounds also follow Lipinski Rule 5. Docking study was carried out for the designed compounds. It's effect of substitution in 3,4-substitution in phenyl ring when compared to that of the non-substituent.
Amino, chloro, hydroxy, methyl, methoxy, bromo, fluro were the substituent's studied in this research work. It was observed that presence of methyl and hydroxyl group as substituent at 3,4-position possess good CDOCKER interaction energy of -40.2868 toward the Raf-B target when compared to that of other substituents with two hydrogen bonding with the target. Reduction in the CDOCKER interaction energy of -37.791was found while interchanging the position. The compounds does not form hydrogen bonds with the target. CDOCKER interaction energy of unsubstituted phenyl group in the chalcone was found to be -27.8466 with one hydrogen bond of distance 2.4758. CDOCKER interaction energy of bromo and methoxy group as substituent in 3,4-position was found to be -36.2798 and -33.9054 respectively. The 3-bromo-4-methoxy group as substitutent was found to possess high interaction energy and two hydrogen bonds when compared to that of 4-bormo-3-methoxy group. 
Conclusion
Twelve chalcone derivatives of 7-azaindole were designed for its Raf-B inhibition. The effect of substitution at 3,4-position was studied. It was found that all the designed compounds follow Lipinski's rule 5 and does not have any problem with ADME. Docking study reveals that all the compounds docked effectively towards the Raf-B target. Among all the designed compounds, substitution at 3-methyl-4-hydroxy group as substitution possesses good CDOCKER interaction energy when compared to that of other compounds. 4-methyl-3-hydroxyl group also possess good interaction energy. All the reports suggests that the presence of methyl and hydroxyl group as substitution at 4 and 3-position increases binding with Raf-B.
